(Q331810)

Statements

0 references

addresses subject

Health Economics and Quality of Life Assessment

35

1 reference

https://openalex.org/I4210153140

Diagnosis and Pathogenesis of Multiple Sclerosis

16

1 reference

https://openalex.org/I4210153140

Chimeric Antigen Receptor T Cell Therapy

16

1 reference

https://openalex.org/I4210153140

Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer

13

1 reference

https://openalex.org/I4210153140

Hemophagocytic Lymphohistiocytosis and Related Disorders

12

1 reference

https://openalex.org/I4210153140

Diagnosis and Treatment of Multiple Myeloma

12

1 reference

https://openalex.org/I4210153140

Epidemiology and Treatment of Childhood Leukemia

10

1 reference

https://openalex.org/I4210153140

Molecular Mechanisms of Amyloidosis

9

1 reference

https://openalex.org/I4210153140

Rheumatoid Arthritis Topics

9

1 reference

https://openalex.org/I4210153140

Economic Burden of Cancer Treatment

8

1 reference

https://openalex.org/I4210153140

Methods for Evidence Synthesis in Research

8

1 reference

https://openalex.org/I4210153140

Reciprocal Development of TH17 and Treg Cells

8

1 reference

https://openalex.org/I4210153140

Global Burden of Chronic Pain

8

1 reference

https://openalex.org/I4210153140

Classification and Treatment of Spondyloarthritis

7

1 reference

https://openalex.org/I4210153140

Guillain-Barré Syndrome and Related Neuropathies

7

1 reference

https://openalex.org/I4210153140

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

7

1 reference

https://openalex.org/I4210153140

Lymphoid Neoplasms

7

1 reference

https://openalex.org/I4210153140

Advancements in Lung Cancer Research

7

1 reference

https://openalex.org/I4210153140

7

1 reference

https://openalex.org/I4210153140

Efficacy and Resistance in CML Treatment

6

1 reference

https://openalex.org/I4210153140

Developmental Pharmacology in Pediatric Drug Use

6

1 reference

https://openalex.org/I4210153140

Pathophysiology of Lumbar Disc Degeneration and Treatment

6

1 reference

https://openalex.org/I4210153140

Immunogenicity of Biosimilar Therapeutics in Drug Development

5

1 reference

https://openalex.org/I4210153140

HER2 Signaling in Breast Cancer Treatment

5

1 reference

https://openalex.org/I4210153140

5

1 reference

https://openalex.org/I4210153140

coordinate location

43°21'29"N, 79°47'53"W

1 reference

https://openalex.org/I4210153140

1 reference

https://openalex.org/I4210153140

official website

https://www.eversana.com/tag/canada/

1 reference

https://openalex.org/I4210153140

0 references

Research Organization Registry ID

0 references

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331810&oldid=1268231"